Pandion stock price
WebFeb 25, 2024 · This morning, Pandion’s stock price has skyrocketed to $59.36 after news of the deal broke. Pandion is advancing a pipeline of precision immune modulators targeting critical immune control nodes. The company’s lead candidate, PT101, is an engineered IL-2 mutein fused to a protein backbone designed to selectively activate and expand ... WebBiotech company Pandion only wrapped its initial public offering seven months ago. But Merck is planning to take over the fledgling company for $60 per share. That represents a roughly 130%...
Pandion stock price
Did you know?
WebOct 5, 2024 · Pandion said Tuesday it raised another $30 million from investors, including AME Cloud Ventures, a firm led by Yahoo co-founder Jerry Yang, and Innovation … WebFeb 25, 2024 · Shares of Pandion Therapeutics have soared more than 131% in premarket trading after pharma giant Merck announced it is acquiring the company for up to $1.85 billion. Merck said the acquisition adds a pipeline of drug candidates that target a broad range of autoimmune diseases.
WebNov 21, 2024 · When Merck and Pandion announced their planned acquisition on February 25, 2024, Pandion’s stock price increased by more than 133 percent, and Brian Wong realized unlawful gains of approximately $400,000. WebPandion Therapeutics Inc (PAND) Try Excel Help Go To: Full Chart Realtime quote and/or trades are not sourced from all markets. Fundamentals See More Market Capitalization, …
WebMar 2, 2024 · NASDAQ:PAND Pandion Therapeutics - PAND Price Target & Analyst Ratings Notice: This company has been marked as potentially delisted and may not be … WebFeb 25, 2024 · Merck’s offer for Pandion Therapeutics has it valuing PAND stock at $60 per share. That’s a massive 134% premium over the stock’s closing price of $25.63 per share on Wednesday. Shares not...
WebKey Stock Data P/E Ratio (TTM) N/A EPS (TTM) $-2.02 Market Cap $312.96 M Shares Outstanding 55.21 M Public Float 32.88 M Yield AMAM is not currently paying a regular …
Webstock, par value $0.001 per share, of Pandion Therapeutics, Inc. (“Pandion”), at a purchase price of $60.00 per share, net to the seller in cash, without interest and less any applicable tax withholding. As of March 1, 2024 (the most recent practicable date): (i) 29,515,583 shares of Pandion common stock were issued and colorado map showing mesa verdeWebPAND - Pandion Therapeutics Stock Price History - Barchart.com or Stocks Options ETFs Futures Currencies Investing News Tools Learn Pandion Therapeutics Inc (PAND) Help Go To: Barchart also offers extensive historical data through Barchart Excel and via API through Barchart OnDemand (Web Services). dr scott majors hermitage tnWebFeb 26, 2024 · Merck & Company agreed to snap up Pandion Therapeutics, a clinical-stage biotechnology company, in a deal worth $1.85 billion. Pandion shares jumped almost 133.4% to close at $59.81 on Feb. 25.Per ... dr scott malay pennWebMar 30, 2024 · PANDION THERAPEUTICS, INC. : Historical chart, prices and data share PANDION THERAPEUTICS, INC. PAND US6983401067 Nasdaq colorado map topographicWebFeb 16, 2024 · As Pandion enters late-stage trials for PT101, the capital intensity for development increases dramatically and without some sort of massive increase in stock … colorado map with cities townsWebFeb 25, 2024 · Merck said Thursday it agreed to acquire Pandion Therapeutics, a clinical-stage biotech firm developing products for patients with autoimmune diseases, in a deal valued at $1.85 billion, amid... dr scott maleyWebNov 23, 2024 · The Last 12 Months Of Insider Transactions At Pandion Therapeutics In fact, the recent purchase by Independent Director Daniel Becker was not their only acquisition of Pandion Therapeutics... colorado marathon course